Literature DB >> 3906318

Calcium antagonism in heart and vascular smooth muscle.

A Fleckenstein.   

Abstract

Calcium antagonism is an unifying concept that offers a common denominator for a multitude of beneficial effects in cardiovascular therapy such as: direct reduction of myocardial energy expenditure and oxygen demand, improvement of myocardial oxygen supply resulting from spasmolytic and vasodilator effects on coronary trunk arteries (including collaterals and anastomoses), lowering of systemic arteriolar resistance (antihypertensive action), indirect diminition of cardiac oxygen requirement due to a fall in afterload, cardioprotection by prevention of excessive myocardial Ca uptake, damping effects on ectopic cardiac automaticity and on reentry pathways (not discussed in the present paper), and possibly anticalcinotic protection of the arterial walls at an advanced age or in cases of premature arterial senescence due to diabetes, hypertension, or nicotine intoxication.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3906318     DOI: 10.1002/med.2610050402

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  5 in total

1.  Failure of the calcium channel activator, Bay K 8644, to increase the release of acetylcholine from nerve terminals in brain and diaphragm.

Authors:  V Dolezal; S Tucek
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

2.  Electrophysiological effects of bepridil and its quaternary derivative CERM 11888 in closed chest anaesthetized dogs: a comparison with verapamil and diltiazem.

Authors:  J Leboeuf; J C Lamar; R Massingham; J Ponsonnaille
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

3.  Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.

Authors:  F T van Amsterdam; M S van Amsterdam-Magnoni; M Haas; N C Punt; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

4.  Dexmedetomidine-induced decrease in cerebral blood flow is attenuated by verapamil in rats: a laser Doppler study.

Authors:  F Bari; G Horváth; G Benedek
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

5.  Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.

Authors:  J Leboeuf; M Basiez; R Massingham
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.